Transactions
11
Insider / Natera, Inc.
ROSENMAN HERM
Director at Natera, Inc.
- Company
- Natera, Inc.
- Ticker
- NTRA
- First filing on record
- December 16, 2025
- Latest trade on record
- June 26, 2026
- SEC filings
- EDGAR ↗
ROSENMAN HERM, Director at Natera, Inc., has disclosed 11 transactions in NTRA since December 16, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $15.1M at the reported prices. The latest was filed June 30, 2026, 4 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
5
Avg. disclosure lag
7.6d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months ROSENMAN HERM made no purchases and 5 sales worth $15M, plus 6 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
ROSENMAN HERM has traded 1 stock on record; the largest by dollars is NTRA.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 6 | 2,247 | — |
| S | Open-market sale | 5 | 64,949 | $15.1M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 6 | 0 | 1 · $4.1M |
| 2025 | 5 | 0 | 4 · $11.0M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | Other A | June 26, 2026 | June 30, 2026 | 4d | 106 | — | — | Form 4 ↗ | ||
| NTRA | Other A | June 26, 2026 | June 30, 2026 | 4d | 1,571 | — | — | Form 4 ↗ | ||
| NTRA | Sell S | June 24, 2026 | June 26, 2026 | 2d | 16,530 | $250 | $4.1M | 10b5-1 plan | Form 4 ↗ | |
| NTRA | Other A | April 24, 2026 | April 28, 2026 | 4d | 222 | — | — | Form 4 ↗ | ||
| NTRA | Other A | April 24, 2026 | April 28, 2026 | 4d | 117 | — | — | Form 4 ↗ | ||
| NTRA | Other A | January 30, 2026 | February 3, 2026 | 4d | 99 | — | — | Form 4 ↗ | ||
| NTRA | Sell S | December 12, 2025 | December 16, 2025 | 4d | 150 | $229 | $34K | Form 4 ↗ | ||
| NTRA | Sell S | December 12, 2025 | December 16, 2025 | 4d | 11,987 | $228 | $2.7M | Form 4 ↗ | ||
| NTRA | Sell S | December 12, 2025 | December 16, 2025 | 4d | 21,910 | $227 | $5.0M | Form 4 ↗ | ||
| NTRA | Sell S | December 12, 2025 | December 16, 2025 | 4d | 14,372 | $227 | $3.3M | Form 4 ↗ | ||
| NTRA | Other A | October 31, 2025 | December 16, 2025 | 46d | 132 | — | — | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 30, 2026 | Form 4 | 0001230057-26-000005 | 2 | published | EDGAR ↗ |
| June 26, 2026 | Form 4 | 0001230057-26-000004 | 1 | published | EDGAR ↗ |
| April 28, 2026 | Form 4 | 0001230057-26-000003 | 2 | published | EDGAR ↗ |
| February 3, 2026 | Form 4 | 0001230057-26-000001 | 1 | published | EDGAR ↗ |
| December 16, 2025 | Form 4 | 0001230057-25-000005 | 5 | published | EDGAR ↗ |
Other insiders at Natera, Inc.
- Sheena Jonathan Director 168 rows
- Rabinowitz Matthew EXECUTIVE CHAIRMAN 127 rows
- BOTHA ROELOF Director 87 rows
- Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS 78 rows
- Chapman Steven Leonard CEO AND PRESIDENT 74 rows
- RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER 55 rows
- Brophy Michael Burkes CHIEF FINANCIAL OFFICER 53 rows
- Fesko John PRESIDENT, CHIEF BUS. OFFICER 23 rows
- Baynes Roy D. Director 19 rows
- Chapman Rowan E Director 13 rows
Everyone on file, with contracts and lobbying under the company's name: Natera, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 11 | December 16, 2025 | June 30, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.